Aharon G. Freud

6.7k total citations · 1 hit paper
76 papers, 4.5k citations indexed

About

Aharon G. Freud is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Aharon G. Freud has authored 76 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Immunology, 23 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Aharon G. Freud's work include Immune Cell Function and Interaction (50 papers), IL-33, ST2, and ILC Pathways (22 papers) and T-cell and B-cell Immunology (20 papers). Aharon G. Freud is often cited by papers focused on Immune Cell Function and Interaction (50 papers), IL-33, ST2, and ILC Pathways (22 papers) and T-cell and B-cell Immunology (20 papers). Aharon G. Freud collaborates with scholars based in United States, France and Japan. Aharon G. Freud's co-authors include Michael A. Caligiuri, Jianhua Yu, Bethany L. Mundy-Bosse, Hsiaoyin Mao, Brian Becknell, Steven D. Scoville, Tiffany Hughes, Amy K. Ferketich, Robert A. Baiocchi and Gerard J. Nuovo and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Blood.

In The Last Decade

Aharon G. Freud

72 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Broad Spectrum of Human Natural Killer Cell Diversity

2017 482 citations Aharon G. Freud, Bethany L. Mundy-Bosse et al. Immunity profile →

Peers

Countries citing papers authored by Aharon G. Freud

Since Specialization

Citations

This map shows the geographic impact of Aharon G. Freud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aharon G. Freud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aharon G. Freud more than expected).

Fields of papers citing papers by Aharon G. Freud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aharon G. Freud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aharon G. Freud. The network helps show where Aharon G. Freud may publish in the future.

Co-authorship network of co-authors of Aharon G. Freud

This figure shows the co-authorship network connecting the top 25 collaborators of Aharon G. Freud. A scholar is included among the top collaborators of Aharon G. Freud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aharon G. Freud. Aharon G. Freud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib 2024 ·Haematologica ·(unknown), Benjamin H. Kaffenberger, Catherine Chung, Eric Samorodnitsky, Emily L. Hoskins, (unknown), Amy Smith, Sarah Wall, Jonathan E. Brammer, Julie W. Reeser, Michele R. Wing, Julia F. Hopkins, Lee A. Albacker, Lynne V. Abruzzo, (unknown), Aharon G. Freud, Sameek Roychowdhury, (unknown)	1
2	Type 3 Innate Lymphoid Cells Promote Acute Myeloid Leukemia Immune Evasion and Expansion 2023 ·Blood ·(unknown), (unknown), (unknown), (unknown), (unknown), Megan Broughton, (unknown), Karilyn Larkin, Christopher C. Oakes, Patrick L. Collins, Aharon G. Freud, Bethany L. Mundy-Bosse	0
3	GATA1 and GATA2 Sense/Antisense Transcriptional Switching in Early Hematopoietic Development 2023 ·Blood ·Erik Anderson, Hongchuan Li, (unknown), (unknown), Aharon G. Freud, Stephen K. Anderson	0
4	Abstract 1351: Uterine natural killer cells display a unique functional dichotomy in human endometrial cancer 2023 ·Cancer Research ·(unknown), (unknown), (unknown), Bethany L. Mundy-Bosse, Paige M. Porrett, Patrick L. Collins, Casey Cosgrove, Aharon G. Freud	0
5	Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma 2020 ·Molecular Cancer Therapeutics ·Melanie A. Krook, (unknown), Max Wilberding, (unknown), (unknown), Kelly M. Bailey, Hui‐Zi Chen, Julie W. Reeser, Michele R. Wing, Jharna Miya, Eric Samorodnitsky, Amy Smith, (unknown), (unknown), Kristen K. Ciombor, John L. Hays, Aharon G. Freud, Sameek Roychowdhury	106
6	Established and emergent roles for Ikaros transcription factors in lymphoid cell development and function 2020 ·Immunological Reviews ·Kaitlin A. Read, (unknown), Aharon G. Freud, Kenneth J. Oestreich	28
7	EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia 2019 ·Clinical Cancer Research ·Marius Bill, (unknown), Malith Karunasiri, Changxian Shen, (unknown), Parvathi Ranganathan, Dimitrios Papaioannou, Nina C. Zitzer, (unknown), (unknown), (unknown), (unknown), Ansel P. Nalin, Aharon G. Freud, Mikhail M. Dikov, Xiaoli Zhang, Clara D. Bloomfield, Ramiro Garzon, Adrienne M. Dorrance	20
8	Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer 2019 ·Prostate Cancer and Prostatic Diseases ·Melanie A. Krook, (unknown), Hui‐Zi Chen, Julie W. Reeser, Michele R. Wing, (unknown), (unknown), (unknown), Russell Bonneville, Eric Samorodnitsky, Jharna Miya, Aharon G. Freud, J. Paul Monk, Steven K. Clinton, Sameek Roychowdhury	5
9	True Detective: Unraveling Group 1 Innate Lymphocyte Heterogeneity 2019 ·Trends in Immunology ·Luke Riggan, Aharon G. Freud, Timothy E. O’Sullivan	49
10	SMAD4 promotes TGF-β–independent NK cell homeostasis and maturation and antitumor immunity 2018 ·Journal of Clinical Investigation ·Youwei Wang, Jianhong Chu, Ping Yi, (unknown), Jennifer N. Saultz, Yufeng Wang, Hongwei Wang, Steven D. Scoville, Jianying Zhang, Lai‐Chu Wu, Youcai Deng, Xiaoming He, Bethany L. Mundy-Bosse, Aharon G. Freud, Li‐Shu Wang, Michael A. Caligiuri, Jianhua Yu	59
11	Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells 2017 ·Frontiers in Immunology ·Steven D. Scoville, Aharon G. Freud, Michael A. Caligiuri	111
12	Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma 2014 ·Human Pathology ·Ryan A. Metcalf, Ahmad Monabati, Monika Vyas, Giovanna Roncador, Gabrıela Gualco, Carlos E. Bacchi, (unknown), Yasodha Natkunam, Aharon G. Freud	28
13	Location and cellular stages of natural killer cell development 2013 ·Trends in Immunology ·Jianhua Yu, Aharon G. Freud, Michael A. Caligiuri	274
14	Evidence for a stepwise program of extrathymic T cell development within the human tonsil 2012 ·Journal of Clinical Investigation ·Susan McClory, Tiffany Hughes, Aharon G. Freud, Edward L. Briercheck, Chelsea K. Martin, Anthony J. Trimboli, Jianhua Yu, Xiaoli Zhang, Gustavo Leone, Gerard J. Nuovo, Michael A. Caligiuri	69
15	In Vivo Role of Flt3 Ligand and Dendritic Cells in NK Cell Homeostasis 2010 ·The Journal of Immunology ·Martin Guimond, Aharon G. Freud, Hsiaoyin Mao, Jianhua Yu, Bradley W. Blaser, Jeffrey Leong, Jeffrey VanDeusen, Adrienne M. Dorrance, Jianying Zhang, Crystal L. Mackall, Michael A. Caligiuri	51
16	Interleukin-1β Selectively Expands and Sustains Interleukin-22+ Immature Human Natural Killer Cells in Secondary Lymphoid Tissue 2010 ·Immunity ·Tiffany Hughes, Brian Becknell, Aharon G. Freud, Susan McClory, Edward L. Briercheck, Jianhua Yu, Charlene Mao, Chiara Giovenzana, Gerard J. Nuovo, Lai Wei, Xiaoli Zhang, Mikhail A. Gavrilin, Mark D. Wewers, Michael A. Caligiuri	165
17	Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells 2008 ·Blood ·Don M. Benson, Jianhua Yu, Brian Becknell, Wei Min, Aharon G. Freud, Amy K. Ferketich, Rossana Trotta, Danilo Perrotti, Roger Briesewitz, Michael A. Caligiuri	39
18	Evidence for discrete stages of human natural killer cell differentiation in vivo 2006 ·The Journal of Experimental Medicine ·Aharon G. Freud, Akihiko Yokohama, Brian Becknell, (unknown), Hsiaoyin Mao, Amy K. Ferketich, Michael A. Caligiuri	322
19	Selective Efficacy of Depsipeptide in a Xenograft Model of Epstein-Barr Virus-Positive Lymphoproliferative Disorder 2004 ·JNCI Journal of the National Cancer Institute ·Sukla Roychowdhury, Robert A. Baiocchi, Srinivas Vourganti, Darshna Bhatt, Bradley W. Blaser, Aharon G. Freud, James J. Chou, Chang‐Shi Chen, Jim Xiao, Mark R. Parthun, Karen K. L. Chan, Charles F. Eisenbeis, Amy K. Ferketich, Michael R. Grever, M. A. Caligiuri	26
20	Fatal Leukemia in Interleukin-15 Transgenic Mice 2001 ·Blood Cells Molecules and Diseases ·Todd A. Fehniger, Kazuhiro Suzuki, Jeffrey VanDeusen, Megan A. Cooper, Aharon G. Freud, (unknown)	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact